Works matching DE "TEVA Pharmaceutical Industries Ltd."


Results: 60
    1
    2
    3
    4
    5

    News Briefs.

    Published in:
    American Journal of Health-System Pharmacy, 2006, v. 63, n. 6, p. 502-a, doi. 10.1093/ajhp/63.6.502a
    Publication type:
    Article
    6

    News Briefs.

    Published in:
    American Journal of Health-System Pharmacy, 2004, v. 61, n. 6, p. 558
    Publication type:
    Article
    7
    8
    9

    US case law developments in 2005.

    Published in:
    Journal of Generic Medicines, 2006, v. 3, n. 3, p. 237, doi. 10.1057/palgrave.jgm.4940125
    By:
    • Braier, Paul A.;
    • Roylance, Stephen M.;
    • Greenblum, Benjamin M.
    Publication type:
    Article
    10
    11
    12

    A Pharmacokinetic Bioequivalence Study of Fremanezumab Administered Subcutaneously Using an Autoinjector and a Prefilled Syringe.

    Published in:
    Clinical Pharmacology in Drug Development, 2021, v. 10, n. 9, p. 1018, doi. 10.1002/cpdd.902
    By:
    • Cherniakov, Irina;
    • Cohen‐Barak, Orit;
    • Tiver, Ryan;
    • Gillespie, Michael;
    • Kessler, Yoel;
    • Gutierrez, Maria;
    • Rasamoelisolo, Michele;
    • Li, Shawn;
    • Shen, Honglue;
    • Hallak, Hussein;
    • Loupe, Pippa S.;
    • Smith, Michael;
    • Rabinovich‐Guilatt, Laura;
    • Spiegelstein, Ofer
    Publication type:
    Article
    13

    Movers & Shakers.

    Published in:
    Chemistry & Industry, 2013, v. 77, n. 5, p. 51, doi. 10.1002/cind.7705_17.x
    Publication type:
    Article
    14

    Business digest.

    Published in:
    Chemistry & Industry, 2011, n. 11, p. 13, doi. 10.1002/cind.7523_4.x
    Publication type:
    Article
    15
    16

    Business digest.

    Published in:
    Chemistry & Industry, 2008, n. 15, p. 15
    By:
    • Eisberg, Neil
    Publication type:
    Article
    17

    Movers & Shakers.

    Published in:
    Chemistry & Industry, 2006, n. 23, p. 16
    Publication type:
    Article
    18

    News in brief.

    Published in:
    Chemistry & Industry, 2005, n. 15, p. 6
    Publication type:
    Article
    19
    20
    21
    22

    Teva loses key MS drug patent.

    Published in:
    Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 656, doi. 10.1038/nrd4123
    By:
    • Harrison, Charlotte
    Publication type:
    Article
    23

    Patent watch.

    Published in:
    Nature Reviews Drug Discovery, 2010, v. 9, n. 2, p. 96, doi. 10.1038/nrd3109
    By:
    • Harrison, Charlotte
    Publication type:
    Article
    24

    Patent Watch.

    Published in:
    Nature Reviews Drug Discovery, 2008, v. 7, n. 8, p. 636, doi. 10.1038/nrd2651
    By:
    • Harrison, Charlotte
    Publication type:
    Article
    25

    News In Brief.

    Published in:
    Nature Reviews Drug Discovery, 2005, v. 4, n. 9, p. 706, doi. 10.1038/nrd1840
    Publication type:
    Article
    26
    27
    28
    29
    30

    Options for multiple sclerosis therapy.

    Published in:
    JAMA: Journal of the American Medical Association, 1994, v. 272, n. 18, p. 1393, doi. 10.1001/jama.1994.03520180017006
    By:
    • Cotton, Paul
    Publication type:
    Article
    31
    32
    33
    34
    35
    36

    From the FDA.

    Published in:
    Brown University Child & Adolescent Psychopharmacology Update, 2007, v. 9, n. 4, p. 8
    Publication type:
    Article
    37
    38
    39
    40
    41

    From the FDA.

    Published in:
    Brown University Psychopharmacology Update, 2006, v. 17, n. 11, p. 8
    Publication type:
    Article
    42

    From the FDA.

    Published in:
    Brown University Psychopharmacology Update, 2006, v. 17, n. 5, p. 8
    Publication type:
    Article
    43
    44
    45
    46
    47

    In brief.

    Published in:
    Nature, 2006, v. 441, n. 7090, p. 149, doi. 10.1038/441149b
    Publication type:
    Article
    48
    49
    50